Track the 엔케이젠바이오텍코리아 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 엔케이젠바이오텍코리아 has recorded 51 public disclosures. The latest transaction was filed on 10 July 2025 (Other). Among the most active insiders: 박근호. The full history is free.
51
Insider Decl.
0
Thresholds
·
25 ops.
Buy Volume
·
0 ops.
Sell Volume
2Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
